Third International Workshop on Focal Therapy and Imaging of Prostate and Kidney Cancer

 

Preliminary Agenda

Sponsored by the Duke University School of Medicine 

 

Time	Topic	Speaker/Moderator
Wednesday, February 24
1:00-7:30 pm	Registration
2:00-6:00 pm	Moderated Poster Sessions Sessions A and B run concurrently
	Session A: Prostate Cancer A-1: Diagnostics/Imaging A-2: Treatment	Thomas Polascik, MD
	Session B: Renal Cancer B-1: Diagnostics/Imaging B-2: Treatment	Inderbir Gill, MD
6:00-7:30 pm	Reception
Thursday, February 25
6:45-7:30 am	Registration/Continental Breakfast
7:25-7:30 am	Welcome and Overview	Thomas Polascik, MD
7:30-10:00 am	Session I: Focal Therapy--Pathological and Molecular Basis	David Bostwick, MD, MBA
7:30-7:45 am	Low Risk Prostate Cancer: Active Surveillance or Focal Therapy	Peter Carroll, MD
7:45-8:00 am	Quality Assurance in Prostate Biopsy Sampling and Processing: Implications for Focal Therapy	David Bostwick, MD, MBA
8:00-8:15 am	Rationale for Focal Therapy Based upon Pathologic Findings	Thomas Wheeler, MD
8:15-8:30 am	Defining the Index Lesion	Hashim Uddin Ahmed, MRCS(Ed), BM, BCh(Oxon), BA(Hons)
8:30-8:45 am	Molecular Biology of Early Prostate Cancer	Carlos Cordon-Cardo, MD
8:45-9:00 am	Molecular Characteristics of Non-Clinically Significant Versus Lethal Metastatic Prostate Cancer	Steve Bova, MD
9:00-9:30 am	Panel Discussion	All Speakers
9:30-10:00 am	Late Breaking News	Vladimir Mouraviev
10:00-10:30 am	Break
10:30-12:15 pm	Session II: Biopsy and Targeting of Prostate Cancer	J. Stephen Jones, MD Daniel Stoianovici, PhD
10:30-10:45 am	Biopsy Strategies to Detect Small Prostate Cancers	J. Stephen Jones, MD
10:45-11:00 am	Computer-Guided Template Biopsy	Samir Taneja, MD
11:00-11:15 am	Biopsy and Imaging Correlation with Modern Technologies	Arnauld Villers, MD
11:15-11:30 am	Stereotactic Targeting of the Prostate--Concept or Reality?	Inderbir Gill, MD
11:30-11:45 am	Image-Guided Robotic Prostate Biopsy	Daniel Stoianovici, PhD
11:45-12:15 pm	Panel Discussion	All Speakers
12:15-1:15 pm	Lunch
1:15-3:15 pm	Session III: Functional and Molecular Imaging of Prostate Cancer	Peter Choyke, MD Jean de la Rosette, MD, PhD
1:15-1:30 pm	Ultrasound Imaging of Prostate Cancer	Jean de la Rosette, MD, PhD
1:30-1:45 pm	Post-Processing of Ultrasound Signal--Histoscanning	Mark Emberton, MD
1:45-2:00 pm	Advances in MRI/MRIS	John Kurhanewicz, PhD
2:00-2:15 pm	Low Molecular Weight Imaging Agents for Prostate Cancer: Focus on PSMA	Martin Pomper, MD, PhD
2:15-2:30 pm	Nanotechnology in Prostate Cancer	Omid Farokhzad, MD
2:30-2:45 pm	New Horizons in Molecular Imaging of Prostate Cancer	Peter Choyke, MD
2:45-3:15 pm	Panel Discussion	All Speakers
3:15-3:45 pm	Break
3:45-4:00 pm	Late Breaking News	Vladimir Mouraviev, MD, PhD
4:00-4:15 pm	Consensus Statement on Prostate Cancer from the 2nd (Amsterdam) Symposium	Jean de la Rosette, MD
4:15-5:00 pm	Prostate Cancer Keynote Lecture:  Novel Biomarkers for Prostate Cancer Detection and Prognosis	Alan Partin, MD, PhD
Friday, February 26
6:45-7:30 am	Continental Breakfast
7:30-9:15 am	Session IV: Focal Ablative Techniques	Arie Belldegrun, PhD John Trachtenberg, MD
7:30-7:45 am	Focal Cryoablation	Aaron Katz, MD
7:45-8:00 am	Focal HIFU (high-intensity focal ultrasound)	Mark Emberton, MD
8:00-8:15 am	Vascular Photodynamic Technology	Vladimir Mouraviev, MD, PhD
8:15-8:30 am	Robot-Guided Interstitial Laser Therapy	John Trachtenberg, MD
8:30-8:45 am	Robotic Partial Prostatectomy	Arnauld Villers, MD
8:45-9:15 am	Panel Discussion	All Speakers
9:15-9:45 am	Break
9:45-11:30 am	Session V: New Concepts in Focal Therapy	Jean de la Rosette, MD Daniel George, MD
9:45-10:00 am	Optimizing Tumor Ablation for Focal Therapy	John Baust, PhD
10:00-10:15 am	Immunotherapy and Ablative Techniques	Arie Belldegrun, MD
10:15-10:30 am	Chemoprevention of the Untreated Prostate Gland	Daniel George, MD
10:30-10:45 am	The Delicate Balance between QoL and Cancer Control	Thomas Polascik, MD
10:45-11:00 am	Penile Rehabilitation in Focal Therapy Setting	John Mulhall, MD
11:00-11:30 am	Panel Discussion	All Speakers
11:30-12:15 pm	Lunch
12:15-3:15 pm	Session VI: How to Implement Focal Therapy Into Clinical Practice--Debates	Thomas Polascik, MD Mark Emberton, MD
12:15-12:45 pm	Focal Therapy Versus Active Surveillance	Peter Carroll, MD Balentine Carter, MD
12:45-1:15 pm	Patient Selection: Based on Biopsy or Imaging	John Trachtenberg, MD Samir Taneja, MD
1:15-1:45 pm	Patient Selection: Conservative Approach Versus Liberal Treatment	Thomas J. Polascik, MD Mark Emberton, MD
1:45-2:15 pm	How Much Should We Ablate? Unifocal Versus Hemiablation	Arnauld Villers, MD Vladimir Mouraviev, MD, PhD
2:15-2:45 pm	Follow Up: PSA Versus Biopsy	Aaron Katz, MD J. Stephen Jones, MD
2:45-3:15 pm	Panel Discussion	All Speakers
3:15-3:45 pm	Break
3:45-6:00 pm	Session VII: Small Renal Masses--Imaging, Biopsy, Selection Criteria	Arie Belldegrun, MD Jens Rassweiler
3:45-4:00 pm	Small Renal Mass--The New Entity	Robert Uzzo, MD
4:00-4:15 pm	Genetic Basis of Kidney Cancer: Disease-specific Approaches to Therapy	Marston Linehan, MD
4:15-4:30 pm	Imaging--Current Status	Hessel Wijkstra, PhD
4:30-4:45 pm	Imaging--Future Perspectives: G-250 (Wilex) Trial Results	Thomas Polascik, MD
4:45-5:00 pm	Navigation in Minimally Invasive Renal Surgery	Jens Rassweiler
5:00-5:15 pm	The Role of Biopsy	Raymond Leveillee, MD, FRCS-G
5:15-5:30 pm	Patient Selection	Jaime Landman, MD
5:00-5:15 pm	Reconciling AUA and EAU Guidelines	Heindrich van Poppel, MD
5:30-6:00 pm	Panel Discussion	All Speakers
6:00-6:45 pm	Renal Cancer Keynote Lecture: Evolution of Renal Cancer Treatment in the Modern Era	Michael Marberger, MD
Saturday, February 27
6:45-7:30 am	Continental Breakfast
7:30-7:45 am	Consensus Statement on Renal Cancer from the 2nd (Amsterdam) Symposium	Pilar Laguna, MD
7:45-11:30 am	Session VIII: Management of Small Renal Masses	Inderbir Gill, MD
7:45-8:00 am	Observation Versus Early Surgery: Who Needs Therapy?	Thomas Jarrett, MD
8:00-8:15 am	Percutaneous Cryoablation	Bruce Shingleton, MD
8:15-8:30 am	Percutaneous RFA (radiofrequency ablation)	Raymond Leveillee, MD, FRCS-G
8:30-8:45 am	Laparoscopic Cryoablation	Jaime Landman, MD
8:45-9:00 am	Laparoscopic RFA	Brandford Wood, MD
9:00-9:15 am	Break
9:15-9:30 am	Renal HIFU	Michael Marberger, MD
9:30-9:45 am	Open Versus Laparoscopic Versus Robotic Versus SILS Partial Nephrectomy	Inderbir Gill, MD
9:45-10:00 am	Combined Treatment for High Risk Patients	Arie Belldegrun, MD
10:00-10:15 am	Follow Up--Is There an Algorithm?	Aradhana Venkatesan, MD
10:15-10:30 am	Dealing with Focal Treatment Failures	Gennady Bratslavsky, MD
10:45-11:15 am	Panel Discussion	All Speakers
11:15-11:30 am	Concluding Remarks	Jean de la Rosette, MD, PhD Inderbir Gill, MD Thomas Polascik, MD